Asthma Outcomes and Management During Pregnancy

Published:September 01, 2017DOI:https://doi.org/10.1016/j.chest.2017.08.029
      Asthma during pregnancy poses a common, increasingly prevalent threat to the health of women and their children. The present article reviews recent insights gained from the epidemiology of asthma during pregnancy, demonstrating the many short- and long-term risks to mother and fetus incurred by poorly controlled maternal asthma. We further discuss emerging evidence that active management of asthma during pregnancy can positively influence and perhaps completely mitigate these poor outcomes. Recent high-quality trials examining best methods for asthma treatment are reviewed and synthesized to offer an evidence-based pathway for comprehensive treatment of asthma in the outpatient setting. Safe and effective medications, as well as nonpharmacologic interventions, for asthma during pregnancy are discussed, and treatment options for related conditions of pregnancy, including depression, rhinitis, and gastroesophageal reflux, are presented. Throughout, we emphasize that an effective treatment strategy relies on a detailed patient evaluation, patient education, objective measurement of asthma control, and frequent and supportive follow-up. The cardiovascular and respiratory physiology of pregnancy is reviewed, as well as its implications for the management of patients with asthma, including patients requiring intubation and mechanical ventilation. For the situation when outpatient asthma management has failed, an approach to the critically ill pregnant patient with status asthmaticus is detailed. Multidisciplinary teams that include pulmonary specialists, obstetricians, primary care providers, nurses, pharmacists, and asthma educators improve the care of pregnant women with asthma.

      Key Words

      Abbreviations:

      ACQ ( Asthma Control Questionnaire), ACT ( Asthma Control Test), ECCO2R ( extracorporeal carbon dioxide removal), ECMO ( extracorporeal membrane oxygenation), ICS ( inhaled corticosteroid), IT ( immunotherapy), LABA ( long-acting beta-agonist), RR ( relative risk), SABA ( short-acting beta-agonist)
      To read this article in full you will need to make a payment
      Subscribe to CHEST
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Petersen J.W.
        • Liu J.
        • Chi Y.Y.
        • et al.
        Comparison of multiple non-invasive methods of measuring cardiac output during pregnancy reveals marked heterogeneity in the magnitude of cardiac output change between women.
        Physiol Rep. 2017; 5 (pii: e13223)
        • LoMauro A.
        • Aliverti A.
        Respiratory physiology of pregnancy: physiology masterclass.
        Breathe (Sheff). 2015; 11: 297-301
        • Rossi A.
        • Cornette J.
        • Johnson M.R.
        • et al.
        Quantitative cardiovascular magnetic resonance in pregnant women: cross-sectional analysis of physiological parameters throughout pregnancy and the impact of the supine position.
        J Cardiovasc Magn Reson. 2011; 13: 31
        • Sroczynski T.
        • Gawlikowska-Sroka A.
        • Dzieciolowska-Baran E.
        • Poziomkowska-Gesicka I.
        Causes of respiratory ailments in pregnancy.
        Eur J Med Res. 2010; 15: 189-192
        • Grindheim G.
        • Toska K.
        • Estensen M.E.
        • Rosseland L.A.
        Changes in pulmonary function during pregnancy: a longitudinal cohort study.
        BJOG. 2012; 119: 94-101
        • Longo L.D.
        Respiratory gas exchange in the placenta.
        in: Comprehensive Physiology. 2011: 351-401 (Accessed October 3, 2017)
        • Soma-Pillay P.
        • Nelson-Piercy C.
        • Tolppanen H.
        • Mebazaa A.
        Physiological changes in pregnancy.
        Cardiovasc J Afr. 2016; 27: 89-94
        • Kwon H.L.
        • Triche E.W.
        • Belanger K.
        • Bracken M.B.
        The epidemiology of asthma during pregnancy: prevalence, diagnosis, and symptoms.
        Immunol Allergy Clin North Am. 2006; 26: 29-62
        • Mendola P.
        • Laughon S.K.
        • Mannisto T.I.
        • et al.
        Obstetric complications among US women with asthma.
        Am J Obstet Gynecol. 2013; 208: 127.e1-127.e8
        • Jolving L.R.
        • Nielsen J.
        • Kesmodel U.S.
        • Nielsen R.G.
        • Beck-Nielsen S.S.
        • Norgard B.M.
        Prevalence of maternal chronic diseases during pregnancy—a nationwide population based study from 1989 to 2013.
        Acta Obstet Gynecol Scand. 2016; 95: 1295-1304
        • Sawicki E.
        • Stewart K.
        • Wong S.
        • Leung L.
        • Paul E.
        • George J.
        Medication use for chronic health conditions by pregnant women attending an Australian maternity hospital.
        Aust N Z J Obstet Gynaecol. 2011; 51: 333-338
        • Kim S.
        • Kim J.
        • Park S.Y.
        • et al.
        Effect of pregnancy in asthma on health care use and perinatal outcomes.
        J Allergy Clin Immunol. 2015; 136: 1215-1223.e1-6
        • Rejno G.
        • Lundholm C.
        • Gong T.
        • Larsson K.
        • Saltvedt S.
        • Almqvist C.
        Asthma during pregnancy in a population-based study—pregnancy complications and adverse perinatal outcomes.
        PLoS One. 2014; 9: e104755
        • Murphy V.E.
        • Namazy J.A.
        • Powell H.
        • et al.
        A meta-analysis of adverse perinatal outcomes in women with asthma.
        BJOG. 2011; 118: 1314-1323
        • Wang G.
        • Murphy V.E.
        • Namazy J.
        • et al.
        The risk of maternal and placental complications in pregnant women with asthma: a systematic review and meta-analysis.
        J Matern Fetal Neonatal Med. 2014; 27: 934-942
        • Murphy V.E.
        • Gibson P.
        • Talbot P.I.
        • Clifton V.L.
        Severe asthma exacerbations during pregnancy.
        Obstet Gynecol. 2005; 106: 1046-1054
        • Murphy V.E.
        • Wang G.
        • Namazy J.A.
        • et al.
        The risk of congenital malformations, perinatal mortality and neonatal hospitalisation among pregnant women with asthma: a systematic review and meta-analysis.
        BJOG. 2013; 120: 812-822
        • Namazy J.A.
        • Murphy V.E.
        • Powell H.
        • Gibson P.G.
        • Chambers C.
        • Schatz M.
        Effects of asthma severity, exacerbations and oral corticosteroids on perinatal outcomes.
        Eur Respir J. 2013; 41: 1082-1090
        • Blais L.
        • Kettani F.Z.
        • Forget A.
        Relationship between maternal asthma, its severity and control and abortion.
        Hum Reprod. 2013; 28: 908-915
        • Blais L.
        • Kettani F.Z.
        • Forget A.
        • Beauchesne M.F.
        • Lemiere C.
        Asthma exacerbations during the first trimester of pregnancy and congenital malformations: revisiting the association in a large representative cohort.
        Thorax. 2015; 70: 647-652
        • Mendola P.
        • Mannisto T.I.
        • Leishear K.
        • Reddy U.M.
        • Chen Z.
        • Laughon S.K.
        Neonatal health of infants born to mothers with asthma.
        J Allergy Clin Immunol. 2014; 133: 85-90.e1-4
        • Murphy V.E.
        • Powell H.
        • Wark P.A.
        • Gibson P.G.
        A prospective study of respiratory viral infection in pregnant women with and without asthma.
        Chest. 2013; 144: 420-427
        • Meijer W.J.
        • van Noortwijk A.G.
        • Bruinse H.W.
        • Wensing A.M.
        Influenza virus infection in pregnancy: a review.
        Acta Obstet Gynecol Scand. 2015; 94: 797-819
        • Hartert T.V.
        • Neuzil K.M.
        • Shintani A.K.
        • et al.
        Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season.
        Am J Obstet Gynecol. 2003; 189: 1705-1712
        • Schanzer D.L.
        • Langley J.M.
        • Tam T.W.
        Influenza-attributed hospitalization rates among pregnant women in Canada 1994-2000.
        J Obstet Gynaecol Can. 2007; 29: 622-629
        • Siston A.M.
        • Rasmussen S.A.
        • Honein M.A.
        • et al.
        Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States.
        JAMA. 2010; 303: 1517-1525
        • Bidad K.
        • Heidarnazhad H.
        • Pourpak Z.
        • Ramazanzadeh F.
        • Zendehdel N.
        • Moin M.
        Frequency of asthma as the cause of dyspnea in pregnancy.
        Int J Gynaecol Obstet. 2010; 111: 140-143
        • Schatz M.
        • Dombrowski M.P.
        • Wise R.
        • et al.
        Asthma morbidity during pregnancy can be predicted by severity classification.
        J Allergy Clin Immunol. 2003; 112: 283-288
        • Kircher S.
        • Schatz M.
        • Long L.
        Variables affecting asthma course during pregnancy.
        Ann Allergy Asthma Immunol. 2002; 89: 463-466
        • Murphy V.E.
        • Clifton V.L.
        • Gibson P.G.
        Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes.
        Thorax. 2006; 61: 169-176
        • Grzeskowiak L.E.
        • Smith B.
        • Roy A.
        • Dekker G.A.
        • Clifton V.L.
        Patterns, predictors and outcomes of asthma control and exacerbations during pregnancy: a prospective cohort study.
        ERJ Open Res. 2016; 2 (pii: 00054-2015)
        • Meakin A.S.
        • Saif Z.
        • Jones A.R.
        • Aviles P.F.V.
        • Clifton V.L.
        Review: placental adaptations to the presence of maternal asthma during pregnancy.
        Placenta. 2017; 54: 17-23
        • Murphy V.E.
        • Mattes J.
        • Powell H.
        • Baines K.J.
        • Gibson P.G.
        Respiratory viral infections in pregnant women with asthma are associated with wheezing in the first 12 months of life.
        Pediatr Allergy Immunol. 2014; 25: 151-158
        • Powell H.
        • Murphy V.E.
        • Taylor D.R.
        • et al.
        Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial.
        Lancet. 2011; 378: 983-990
        • Mattes J.
        • Murphy V.E.
        • Powell H.
        • Gibson P.G.
        Prenatal origins of bronchiolitis: protective effect of optimised asthma management during pregnancy.
        Thorax. 2014; 69: 383-384
        • Gunawardhana L.P.
        • Baines K.J.
        • Mattes J.
        • Murphy V.E.
        • Simpson J.L.
        • Gibson P.G.
        Differential DNA methylation profiles of infants exposed to maternal asthma during pregnancy.
        Pediatr Pulmonol. 2014; 49: 852-862
        • Murphy V.E.
        • Gibson P.G.
        • Talbot P.I.
        • Kessell C.G.
        • Clifton V.L.
        Asthma self-management skills and the use of asthma education during pregnancy.
        Eur Respir J. 2005; 26: 435-441
        • Zairina E.
        • Abramson M.J.
        • McDonald C.F.
        • et al.
        Telehealth to improve asthma control in pregnancy: a randomized controlled trial.
        Respirology. 2016; 21: 867-874
        • Lim A.S.
        • Stewart K.
        • Abramson M.J.
        • Walker S.P.
        • Smith C.L.
        • George J.
        Multidisciplinary Approach to Management of Maternal Asthma (MAMMA): a randomized controlled trial.
        Chest. 2014; 145: 1046-1054
        • Grzeskowiak L.E.
        • Smith B.
        • Roy A.
        • Dekker G.A.
        • Clifton V.L.
        An observational study of the impact of an antenatal asthma management service on asthma control during pregnancy.
        Eur J Obstet Gynecol Reprod Biol. 2016; 197: 48-53
        • Tinker S.C.
        • Broussard C.S.
        • Frey M.T.
        • Gilboa S.M.
        Prevalence of prescription medication use among non-pregnant women of childbearing age and pregnant women in the United States: NHANES, 1999-2006.
        Matern Child Health J. 2015; 19: 1097-1106
        • Powell H.
        • McCaffery K.
        • Murphy V.E.
        • et al.
        Psychosocial outcomes are related to asthma control and quality of life in pregnant women with asthma.
        J Asthma. 2011; 48: 1032-1040
        • Gent J.F.
        • Kezik J.M.
        • Hill M.E.
        • et al.
        Asthma medication use during pregnancy, wheeze and estimated exposure to ambient nitrogen dioxide.
        Eur Respir J. 2015; 45: 538-540
        • Baarnes C.B.
        • Hansen A.V.
        • Ulrik C.S.
        Enrolment in an asthma management program during pregnancy and adherence with inhaled corticosteroids: the ‘Management of Asthma during Pregnancy' program.
        Respiration. 2016; 92: 9-15
        • National Heart, Lung, and Blood Institute; National Asthma Education and Prevention Program Asthma Pregnancy Working Group
        NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update.
        J Allergy Clin Immunol. 2005; 115: 34-46
        • Mendola P.
        • Wallace M.
        • Liu D.
        • Robledo C.
        • Mnnist T.
        • Grantz K.L.
        Air pollution exposure and preeclampsia among US women with and without asthma.
        Environ Res. 2016; 148: 248-255
        • Mendola P.
        • Wallace M.
        • Hwang B.S.
        • et al.
        Preterm birth and air pollution: critical windows of exposure for women with asthma.
        J Allergy Clin Immunol. 2016; 138: 432-440.e5
        • Metzger W.J.
        • Turner E.
        • Patterson R.
        The safety of immunotherapy during pregnancy.
        J Allergy Clin Immunol. 1978; 61: 268-272
        • Shaikh W.A.
        A retrospective study on the safety of immunotherapy in pregnancy.
        Clin Exp Allergy. 1993; 23: 857-860
        • Shaikh W.A.
        • Shaikh S.W.
        A prospective study on the safety of sublingual immunotherapy in pregnancy.
        Allergy. 2012; 67: 741-743
        • Schwartz H.J.
        • Golden D.B.
        • Lockey R.F.
        Venom immunotherapy in the Hymenoptera-allergic pregnant patient.
        J Allergy Clin Immunol. 1990; 85: 709-712
        • Oykhman P.
        • Kim H.L.
        • Ellis A.K.
        Allergen immunotherapy in pregnancy.
        Allergy Asthma Clin Immunol. 2015; 11: 31
        • Cox L.
        • Nelson H.
        • Lockey R.
        • et al.
        Allergen immunotherapy: a practice parameter third update.
        J Allergy Clin Immunol. 2011; 127: S1-S55
        • Pitsios C.
        • Demoly P.
        • Bilo M.B.
        • et al.
        Clinical contraindications to allergen immunotherapy: an EAACI position paper.
        Allergy. 2015; 70: 897-909
        • Flicker S.
        • Marth K.
        • Kofler H.
        • Valenta R.
        Placental transfer of allergen-specific IgG but not IgE from a specific immunotherapy-treated mother.
        J Allergy Clin Immunol. 2009; 124: 1358-1360.e1
        • Jenmalm M.C.
        • Bjorksten B.
        Cord blood levels of immunoglobulin G subclass antibodies to food and inhalant allergens in relation to maternal atopy and the development of atopic disease during the first 8 years of life.
        Clin Exp Allergy. 2000; 30: 34-40
        • Lieberman J.
        Should we encourage allergen immunotherapy during pregnancy?.
        Expert Rev Clin Immunol. 2014; 10: 317-319
        • Powell H.
        • Murphy V.E.
        • Hensley M.J.
        • Giles W.
        • Clifton V.L.
        • Gibson P.G.
        Rhinitis in pregnant women with asthma is associated with poorer asthma control and quality of life.
        J Asthma. 2015; 52: 1023-1030
        • Garavello W.
        • Somigliana E.
        • Acaia B.
        • Gaini L.
        • Pignataro L.
        • Gaini R.M.
        Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study.
        Int Arch Allergy Immunol. 2010; 151: 137-141
        • Ellegard E.K.
        • Hellgren M.
        • Karlsson N.G.
        Fluticasone propionate aqueous nasal spray in pregnancy rhinitis.
        Clin Otolaryngol Allied Sci. 2001; 26: 394-400
        • Kallen B.
        Use of antihistamine drugs in early pregnancy and delivery outcome.
        J Matern Fetal Neonatal Med. 2002; 11: 146-152
        • Werler M.M.
        Teratogen update: pseudoephedrine.
        Birth Defects Res A Clin Mol Teratol. 2006; 76: 445-452
        • Harding S.M.
        Gastroesophageal reflux: a potential asthma trigger.
        Immunol Allergy Clin North Am. 2005; 25: 131-148
        • Bidad K.
        • Heidarnazhad H.
        • Pourpak Z.
        • Shayestefar G.
        • Moayeri H.
        • Zendehdel N.
        Gastroesophagial reflux disease and asthma in pregnant women with dyspnea.
        Iran J Allergy Asthma Immunol. 2014; 13: 104-109
        • van der Woude C.J.
        • Metselaar H.J.
        • Danese S.
        Management of gastrointestinal and liver diseases during pregnancy.
        Gut. 2014; 63: 1014-1023
        • Grzeskowiak L.E.
        • Smith B.
        • Roy A.
        • et al.
        Impact of a history of maternal depression and anxiety on asthma control during pregnancy.
        J Asthma. 2017; 54: 706-713
        • Palmsten K.
        • Schatz M.
        • Chan P.H.
        • Johnson D.L.
        • Chambers C.D.
        Validation of the Pregnancy Asthma Control Test.
        J Allergy Clin Immunol Pract. 2016; 4: 310-315.e1
        • de Araujo G.V.
        • Leite D.F.
        • Rizzo J.A.
        • Sarinho E.S.
        Asthma in pregnancy: association between the Asthma Control Test and the Global Initiative for Asthma classification and comparisons with spirometry.
        Eur J Obstet Gynecol Reprod Biol. 2016; 203: 25-29
        • Beckmann C.A.
        Peak flow values by gestation in women with asthma.
        Clin Nurs Res. 2008; 17: 174-181
        • Price D.B.
        • Román-Rodríguez M.
        • McQueen R.B.
        • et al.
        Inhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomes.
        J Allergy Clin Immunol Pract. 2017; 5: 1071-1081.e9
        • Charlton R.A.
        • Pierini A.
        • Klungsoyr K.
        • et al.
        Asthma medication prescribing before, during and after pregnancy: a study in seven European regions.
        BMJ Open. 2016; 6: e009237
        • Beau A.B.
        • Didier A.
        • Hurault-Delarue C.
        • Montastruc J.L.
        • Lacroix I.
        • Damase-Michel C.
        Prescription of asthma medications before and during pregnancy in France: an observational drug study using the EFEMERIS database.
        J Asthma. 2017; 54: 258-264
        • Delea T.E.
        • Hagiwara M.
        • Stempel D.A.
        • Stanford R.H.
        Adding salmeterol to fluticasone propionate or increasing the dose of fluticasone propionate in patients with asthma.
        Allergy Asthma Proc. 2010; 31: 211-218
        • Eltonsy S.
        • Forget A.
        • Beauchesne M.F.
        • Blais L.
        Risk of congenital malformations for asthmatic pregnant women using a long-acting beta(2)-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
        J Allergy Clin Immunol. 2015; 135: 123-130
        • Cossette B.
        • Forget A.
        • Beauchesne M.F.
        • et al.
        Impact of maternal use of asthma-controller therapy on perinatal outcomes.
        Thorax. 2013; 68: 724-730
        • Charlton R.A.
        • Snowball J.M.
        • Nightingale A.L.
        • Davis K.J.
        Safety of fluticasone propionate prescribed for asthma during pregnancy: a UK population-based cohort study.
        J Allergy Clin Immunol Pract. 2015; 3: 772-779.e3
        • Cossette B.
        • Beauchesne M.F.
        • Forget A.
        • et al.
        Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy.
        Ann Allergy Asthma Immunol. 2014; 112: 459-464
        • Nelsen L.M.
        • Shields K.E.
        • Cunningham M.L.
        • et al.
        Congenital malformations among infants born to women receiving montelukast, inhaled corticosteroids, and other asthma medications.
        J Allergy Clin Immunol. 2012; 129: 251-254.e1-6
        • Sarkar M.
        • Koren G.
        • Kalra S.
        • et al.
        Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes.
        Eur J Clin Pharmacol. 2009; 65: 1259-1264
        • Namazy J.
        • Cabana M.D.
        • Scheuerle A.E.
        • et al.
        The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy.
        J Allergy Clin Immunol. 2015; 135: 407-412
        • Hanania N.A.
        • Belfort M.A.
        Acute asthma in pregnancy.
        Crit Care Med. 2005; 33: S319-S324
        • Chan A.L.
        • Juarez M.M.
        • Gidwani N.
        • Albertson T.E.
        Management of critical asthma syndrome during pregnancy.
        Clin Rev Allergy Immunol. 2015; 48: 45-53
        • Al-Ansari M.A.
        • Hameed A.A.
        • Al-jawder S.E.
        • Saeed H.M.
        Use of noninvasive positive pressure ventilation during pregnancy: case series.
        Ann Thorac Med. 2007; 2: 23-25
        • Allred C.C.
        • Matias Esquinas A.
        • Caronia J.
        • Mahdavi R.
        • Mina B.A.
        Successful use of noninvasive ventilation in pregnancy.
        Eur Respir Rev. 2014; 23: 142-144
        • Dalar L.
        • Caner H.
        • Eryuksel E.
        • Kosar F.
        Application of non-invasive mechanical ventilation in an asthmatic pregnant woman in respiratory failure: a case report.
        J Thorac Dis. 2013; 5: 97-100
        • Leatherman J.W.
        • McArthur C.
        • Shapiro R.S.
        Effect of prolongation of expiratory time on dynamic hyperinflation in mechanically ventilated patients with severe asthma.
        Crit Care Med. 2004; 32: 1542-1545
        • Bellomo R.
        • McLaughlin P.
        • Tai E.
        • Parkin G.
        Asthma requiring mechanical ventilation. A low morbidity approach.
        Chest. 1994; 105: 891-896
        • Peters J.I.
        • Stupka J.E.
        • Singh H.
        • et al.
        Status asthmaticus in the medical intensive care unit: a 30-year experience.
        Respir Med. 2012; 106: 344-348
        • Tuuli M.G.
        • Stout M.J.
        • Shanks A.
        • Odibo A.O.
        • Macones G.A.
        • Cahill A.G.
        Umbilical cord arterial lactate compared with pH for predicting neonatal morbidity at term.
        Obstet Gynecol. 2014; 124: 756-761
        • Elsayegh D.
        • Shapiro J.M.
        Management of the obstetric patient with status asthmaticus.
        J Intensive Care Med. 2008; 23: 396-402
        • Mikkelsen M.E.
        • Woo Y.J.
        • Sager J.S.
        • Fuchs B.D.
        • Christie J.D.
        Outcomes using extracorporeal life support for adult respiratory failure due to status asthmaticus.
        ASAIO J. 2009; 55: 47-52
        • Steinack C.
        • Lenherr R.
        • Hendra H.
        • Franzen D.
        The use of life-saving extracorporeal membrane oxygenation (ECMO) for pregnant woman with status asthmaticus.
        J Asthma. 2017; 54: 84-88
        • Nair P.
        • Davies A.R.
        • Beca J.
        • et al.
        Extracorporeal membrane oxygenation for severe ARDS in pregnant and postpartum women during the 2009 H1N1 pandemic.
        Intensive Care Med. 2011; 37: 648-654
        • Combes A.
        • Pesenti A.
        • Ranieri V.M.
        Fifty years of research in ARDS. Is extracorporeal circulation the future of acute respiratory distress syndrome management?.
        Am J Respir Crit Care Med. 2017; 195: 1161-1170
        • Lapinsky S.E.
        • Rojas-Suarez J.A.
        • Crozier T.M.
        • et al.
        Mechanical ventilation in critically-ill pregnant women: a case series.
        Int J Obstet Anesth. 2015; 24: 323-328